======= TCEAL7 ======= == Gene Information == * **Official Symbol**: TCEAL7 * **Official Name**: transcription elongation factor A like 7 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=56849|56849]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9BRU2|Q9BRU2]] * **Interactions**: [[https://thebiogrid.org/search.php?search=TCEAL7&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20TCEAL7|Open PubMed]] * **OMIM**: [[https://omim.org/entry/300771|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Plays a role in the negative regulation of NF-kappa-B signaling at the basal level by modulating transcriptional activity of NF-kappa-B on its target gene promoters. Associates with cyclin D1 promoter containing Myc E-box sequence and transcriptionally represses cyclin D1 expression. Regulates telomerase reverse transcriptase expression and telomerase activity in both ALT (alternative lengthening of telomeres)and telomerase-positive cell lines. {ECO:0000269|PubMed:18806825, ECO:0000269|PubMed:19966855, ECO:0000269|PubMed:20454512}. |BEX| |WW domain binding| |negative regulation of NF-kappaB transcription factor activity| |negative regulation of DNA-binding transcription factor activity| |regulation of DNA-binding transcription factor activity| |negative regulation of molecular function| |negative regulation of transcription, DNA-templated| |negative regulation of nucleic acid-templated transcription| |negative regulation of RNA biosynthetic process| |negative regulation of RNA metabolic process| |negative regulation of cellular macromolecule biosynthetic process| |negative regulation of nucleobase-containing compound metabolic process| |negative regulation of macromolecule biosynthetic process| |negative regulation of cellular biosynthetic process| |negative regulation of biosynthetic process| |negative regulation of gene expression| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp498|Lead acetate 2000μM R08 exp498 no dilution day6]]|-1.91| |[[:results:exp66|BI-D1870 3.15μM R02 exp66]]|-1.83| |[[:results:exp112|S-DABN 8μM R03 exp112]]|-1.79| |[[:results:exp146|Quinacrine 2.5μM R03 exp146]]|-1.78| |[[:results:exp528|TGF-beta1 44ng/ml R08 exp528]]|-1.72| |[[:results:exp435|JQ1 0.8μM R08 exp435]]|1.7| |[[:results:exp208|Vinblastine 0.015μM R05 exp208]]|1.78| |[[:results:exp335|Aminopterin 0.005μM R07 exp335]]|1.95| |[[:results:exp242|Radicicol 0.16μM R05 exp242]]|2.37| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/683 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/26| |bone|0/25| |breast|0/30| |central nervous system|0/49| |cervix|0/4| |colorectal|0/17| |esophagus|0/11| |fibroblast|0/1| |gastric|0/14| |kidney|0/18| |liver|0/19| |lung|0/72| |lymphocyte|0/14| |ovary|0/25| |pancreas|0/22| |peripheral nervous system|0/15| |plasma cell|0/12| |prostate|0/1| |skin|0/20| |soft tissue|0/7| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/28| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 13335 * **Expression level (log2 read counts)**: -3.28 {{:chemogenomics:nalm6 dist.png?nolink |}}